Analysis of the expression profiles of cytokines and cytokine-related genes during the progression of breast cancer growth in mice

被引:26
作者
Jung, Mi Young [1 ]
Kim, Seung Hyun [1 ]
Cho, Daeho [2 ]
Kim, Tae Sung [1 ]
机构
[1] Korea Univ, Sch Life Sci & Biotechnol, Div Life Sci, Seoul 136701, South Korea
[2] Sookmyung Womens Univ, Dept Life Sci, Seoul 140742, South Korea
关键词
breast cancer; DNA microarray; cytokine; interleukin-18; LEUKEMIA-CELLS; CHEMOKINE RECEPTORS; CXC CHEMOKINE; UP-REGULATION; TUMOR-GROWTH; INTERLEUKIN-18; METASTASIS; CARCINOMA; IL-18; MIGRATION;
D O I
10.3892/or_00000547
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cytokines are a protein family of regulatory factors derived from tumors and their environmental components that contribute to the growth, invasion and metastasis of breast cancer. However, the way in which tumor progression and cytokines regulate each other is not well understood. In this study, we used an oligoDNA microarray to assess the kinetic expression profile of cytokine genes in tumor tissues and lymph nodes during the progression of tumor growth in mice that had been subcutaneously challenged with breast adenocarcinoma SB5b cells. Our results demonstrated that IL-15, IL-17, IL-18 and IL-18 binding protein (IL-18bp), which are associated with inflammation, were increased in tumor tissues. Conversely, chemokines and their receptors, including CXCR4/CXCL12, CCR7/CCL21, CCL9, CXCL9 and CCL12, were overexpressed in lymph nodes during tumor growth. Furthermore, RT-PCR and Western blot analysis revealed that IL-18, a pro-angiogenic factor in tumors, was up-regulated in tumor tissues. Interestingly, CCR3, IL-1R2, SOCS and IL-20 were up-regulated in tumor tissues, but down-regulated in lymph nodes during tumor growth. This result suggests that the expression of cytokines and cytokine-related genes was differentially regulated, which resulted in a beneficial effect for tumor progression.
引用
收藏
页码:1141 / 1147
页数:7
相关论文
共 30 条
[1]   The CXC chemokine, monokine induced by interferon-γ, inhibits non-small cell lung carcinoma tumor growth and metastasis [J].
Addison, CL ;
Arenberg, DA ;
Morris, SB ;
Xue, YY ;
Burdick, MD ;
Mulligan, MS ;
Iannettoni, MD ;
Strieter, RM .
HUMAN GENE THERAPY, 2000, 11 (02) :247-261
[2]   Cancer and the chemokine network [J].
Balkwill, F .
NATURE REVIEWS CANCER, 2004, 4 (07) :540-550
[3]   Interleukin-18-induced human coronary artery smooth muscle cell migration is dependent on NF-κB- and AP-1-mediated matrix metalloproteinase-9 expression and is inhibited by atorvastatin [J].
Chandrasekar, Bysani ;
Mummidi, Srinivas ;
Mahimainathan, Lenin ;
Patel, Devang N. ;
Bailey, Steven R. ;
Imam, Syed Z. ;
Greene, Warner C. ;
Valente, Anthony J. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (22) :15099-15109
[4]  
Cho D, 2000, CANCER RES, V60, P2703
[5]   Interferon regulatory factor 1 (IRF-1) and IRF-2 expression in breast cancer tissue microarrays [J].
Connett, JM ;
Badri, L ;
Giordano, TJ ;
Connett, WC ;
Doherty, GM .
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2005, 25 (10) :587-594
[6]   Stromal cell-derived factor-1 and CXCR4 receptor interaction in tumor growth and metastasis of breast cancer [J].
Dewan, M. Z. ;
Ahmed, S. ;
Iwasaki, Y. ;
Ohba, K. ;
Toi, M. ;
Yamamoto, N. .
BIOMEDICINE & PHARMACOTHERAPY, 2006, 60 (06) :273-276
[7]   Protein expression profiling in high-risk breast cancer patients treated with high-dose or conventional dose-dense chemotherapy [J].
Diallo-Danebrock, Raihanatou ;
Ting, Evelyn ;
Gluz, Oleg ;
Herr, Alexander ;
Mohrmann, Svjetlana ;
Geddert, Helene ;
Rody, Achim ;
Schaefer, Karl-Ludwig ;
Baldus, Stephan E. ;
Hartmann, Arndt ;
Wild, Peter J. ;
Burson, Michael ;
Gabbert, Helmut E. ;
Nitz, Ulrike ;
Poremba, Christopher .
CLINICAL CANCER RESEARCH, 2007, 13 (02) :488-497
[8]  
Eissa Soheir A L, 2005, J Egypt Natl Canc Inst, V17, P51
[9]   Clinical importance of serum interleukin-18 and nitric oxide activities in breast carcinoma patients [J].
Günel, N ;
Coskun, U ;
Sancak, B ;
Günel, U ;
Hasdemir, O ;
Bozkurt, S .
CANCER, 2002, 95 (03) :663-667
[10]   Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway [J].
Heinrich, PC ;
Behrmann, I ;
Müller-Newen, G ;
Schaper, F ;
Graeve, L .
BIOCHEMICAL JOURNAL, 1998, 334 :297-314